MissionIR Articles
-
ModusLink Global Solutions, Inc. (MLNK) Forges Collaborative Agreement with PagBrasil, Expands e-Commerce Support to Brazil
ModusLink Global Solutions has announced a collaboration with PagBrasil to provide e-commerce transaction support in Brazil. Payment options and tax issues are complex in that country, but with this new agreement ModusLink will be able…
-
Vimicro International Corp. (VIMC) Enters Joint Venture in Shanxi Province to Expand Security-Surveillance Business
Vimicro International said today it has entered a joint venture with Shanxi Guoxin Investment Corp. (“Guoxin Group”) to form a subsidiary that will make and sell Surveillance Video and Audio Coding (“SVAC”) based security products…
-
Transcept Pharmaceuticals, Inc. (TSPT) Finishes Patient Enrollment in Phase 2 Trial of TO-2061
Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. One such product in the company’s pipeline is TO-2061,…
-
Altairnano, Inc. (ALTI) and Shenhua Science & Technology Sign Memorandum of Understanding
It was recently announced that an agreement was signed by three parties to develop, deploy, and promote industrial applications of lithium titanate-based energy storage systems in China. Altairnano, Shenhua Science & Technology (Shenhua S&T) and…
-
Gilat Satellite Networks Ltd. (GILT) Subsidiary Installs VSAT Technology in 10,000th Dollar General Store
Gilat Satellite Networks, a global leader in satellite networking technology, solutions, and services, announced today that Spacenet, Inc., a wholly owned subsidiary of Gilat and prominent provider of managed network and data security services, has…
-
SFDA Approval Granted for Dehaier Medical Ltd. (DHRM) DHR-CPAP-C5 Device for Treating Sleep Apnea
Dehaier Medical Systems announced that it has obtained State Food and Drug Administration approval for DHR-CPAP-C5, one of the company’s primary proprietary homecare medical devices. The validity period for the SFDA approval is four years.…
-
Lexicon Pharmaceuticals, Inc. (LXRX) Video Chart for Wednesday, September 12, 2012
LXRX has been holding a steady uptrend throughout 2012. After a recent pullback from highs of $3.28, the chart is on the incline again and testing the 50-day moving average as the indicators show a…
-
Extensive Medical Industry Experience Links Cardium Therapeutics, Inc. (CXM) Management Team
Cardium Therapeutics, a San Diego based health sciences and regenerative medicine company, is focused on the acquisition and development of new and innovative bio-medical product opportunities and businesses offering the potential of addressing significant unmet…
-
Adherex Technologies, Inc. (AHX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Adherex Technologies, a biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics, aims to increase the longevity and improve the quality of life for cancer patients. The company is developing Eniluracil, an…
-
NeuroMetrix, Inc. (NURO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
NeuroMetrix is a medical device company that develops and markets home use and point-of-care devices, associated consumables, and support software for the treatment and management of diabetes and its complications. The company markets the NC-stat®…
-
Amorfix Life Sciences Ltd. (AMF) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Amorfix Life Sciences is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including ALS, cancer and Alzheimer’s disease. AMF currently offers four types of products: therapeutics, diagnostic kits, diagnostic services…
-
Sernova Corp. (SVA) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Sernova is a clinical stage health-sciences company focused on commercializing medical technologies. The company is currently developing a platform technology for a number of serious disease indications, starting with a novel treatment for insulin-dependent diabetes,…
-
Allon Therapeutics, Inc. (NPC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Allon Therapeutics is a clinical-stage biotechnology company focused on innovative central nervous system therapies. NPC’s lead drug davunetide is currently in a fully enrolled pivotal phase 2/3 clinical trial in an orphan indication, progressive supranuclear…
-
iBio, Inc. (IBIO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
iBio develops and offers product applications of its iBioLaunch™ platform, which provides collaborators full support for turn-key implementation of the company’s technology for both proprietary and biosimilar products. IBIO’s iBioLaunch platform is a proprietary, transformative…
-
Cellceutix Corp. (CTIX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Cellceutix is an emerging biopharmaceutical company focused on the development of its pipeline of compounds targeting areas of unmet medical need. CTIX’ flagship compound is Kevetrin™, an anti-cancer drug. The company also owns the rights…
-
MRI Interventions, Inc. (MRIC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
MRI Interventions creates innovative platforms for performing minimally invasive surgical procedures in the brain and heart. By utilizing a hospital’s existing MRI suite, MRIC’s FDA-cleared ClearPoint® system is designed to enable a range of minimally…
-
AtheroNova, Inc. (AHRO) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
AtheroNova operates through its wholly owned subsidiary, AtheroNova Operations Inc., as an early stage biotech company focused on the discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits. AHRO…
-
Echo Therapeutics, Inc. (ECTE) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Echo Therapeutics is a transdermal medical device company specializing in advanced skin permeation technology. ECTE is developing its Prelude® SkinPrep System as a platform technology to allow for significantly enhanced and painless skin permeation that…
-
Gasco Energy, Inc. (GSX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
Gasco Energy is an independent oil and gas company engaged in the development of large natural gas deposits in the U.S. Rocky Mountain region and on exploratory oil plays in the San Joaquin Basin in…
-
ACADIA Pharmaceuticals, Inc. (ACAD) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference
ACADIA Pharmaceuticals is a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders. The company’s pipeline of product includes pimavanserin, which is in phase 3…
Search Articles
Latest Articles
- BluSky AI Inc. (BSAI): Democratizing AI Through Modular Infrastructure and a New Neocloud That Scales from Startup to Enterprise
- MissionIRNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Integrates Chainlink Data Services Into Tokenized Money Market Fund
- Brera Holdings PLC (NASDAQ: BREA) Gains Outperform Rating from PartnerCap Securities, Price Target Set at $11.50
- MissionIRNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Advances Predictive Power in Cancer Drug Development
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Positioned to Drive RapidSX(TM) Toward Commercial Launch